These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16179863)

  • 1. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line.
    Zhu BK; Pruitt SC
    Melanoma Res; 2005 Oct; 15(5):363-73. PubMed ID: 16179863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo.
    Pruitt SC; Bussman A; Maslov AY; Natoli TA; Heinaman R
    Gene Expr Patterns; 2004 Oct; 4(6):671-85. PubMed ID: 15465489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
    Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
    Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.
    Kamaraju AK; Bertolotto C; Chebath J; Revel M
    J Biol Chem; 2002 Apr; 277(17):15132-41. PubMed ID: 11830592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors.
    Smit DJ; Smith AG; Parsons PG; Muscat GE; Sturm RA
    Eur J Biochem; 2000 Nov; 267(21):6413-22. PubMed ID: 11029584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative dimerization of the POU domain protein Brn-2 on a new motif activates the neuronal promoter of the human aromatic L-amino acid decarboxylase gene.
    Dugast-Darzacq C; Egloff S; Weber MJ
    Brain Res Mol Brain Res; 2004 Jan; 120(2):151-63. PubMed ID: 14741405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.
    Christova T; Mojtahedi G; Hamel PA
    Int J Biochem Cell Biol; 2010 May; 42(5):630-40. PubMed ID: 20006729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between the paired domain and the homeodomain of Pax3: DNA binding by each domain causes a structural change in the other domain, supporting interdependence for DNA Binding.
    Apuzzo S; Abdelhakim A; Fortin AS; Gros P
    J Biol Chem; 2004 Aug; 279(32):33601-12. PubMed ID: 15148315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the expression of cathepsin B in B16 melanoma metastatic variants depend on transcription factor Sp1.
    Sitabkhan Y; Frankfater A
    DNA Cell Biol; 2007 Sep; 26(9):673-82. PubMed ID: 17691867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a discrete promoter region of the human GnRH gene that is sufficient for directing neuron-specific expression: a role for POU homeodomain transcription factors.
    Wolfe A; Kim HH; Tobet S; Stafford DE; Radovick S
    Mol Endocrinol; 2002 Mar; 16(3):435-49. PubMed ID: 11875100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin stimulates the expression of carbohydrate response element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor-1.
    Sirek AS; Liu L; Naples M; Adeli K; Ng DS; Jin T
    Endocrinology; 2009 Aug; 150(8):3483-92. PubMed ID: 19359385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.
    Corry GN; Underhill DA
    Pigment Cell Res; 2005 Dec; 18(6):427-38. PubMed ID: 16280008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
    Eisen T; Easty DJ; Bennett DC; Goding CR
    Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXD3 Promotes PAX3 Expression in Melanoma Cells.
    Kubic JD; Little EC; Kaiser RS; Young KP; Lang D
    J Cell Biochem; 2016 Feb; 117(2):533-41. PubMed ID: 26252164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
    Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
    Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.
    Bondurand N; Pingault V; Goerich DE; Lemort N; Sock E; Le Caignec C; Wegner M; Goossens M
    Hum Mol Genet; 2000 Aug; 9(13):1907-17. PubMed ID: 10942418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caudal-related homeobox (Cdx) protein-dependent integration of canonical Wnt signaling on paired-box 3 (Pax3) neural crest enhancer.
    Sanchez-Ferras O; Coutaud B; Djavanbakht Samani T; Tremblay I; Souchkova O; Pilon N
    J Biol Chem; 2012 May; 287(20):16623-35. PubMed ID: 22457346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An octamer-binding site is crucial for the activity of an enhancer active at the embryonic met-/mesencephalic junction.
    Mihailescu D; Küry P; Monard D
    Mech Dev; 1999 Jun; 84(1-2):55-67. PubMed ID: 10473120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.